JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB280055

Mouse PRKAA1 knockout RAW 264.7 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

PRKAA1 KO cell line available to order. KO validated by Western blot. Free of charge wild type control available. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

5''-AMP-activated protein kinase catalytic subunit alpha-1, AAPK1_HUMAN, ACACA kinase, AMPK subunit alpha-1, Acetyl-CoA carboxylase kinase, HMGCR kinase, Hydroxymethylglutaryl-CoA reductase kinase, PRKAA 1, Tau-protein kinase PRKAA1

3 Images
Western blot - Mouse PRKAA1 knockout RAW 264.7 cell line (AB280055)
  • WB

Lab

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell line (AB280055)

False colour image of Western blot : Anti-AMPK alpha 1 antibody [2B7] staining at 1/500 dilution shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution shown in red. In Western blot ab110036 was shown to bind specifically to AMPK alpha 1. A band was observed at 64 kDa in wild-type RAW 264.7 cell lysates with no signal observed at this size in PRKAA1 knockout cell line ab280055 (knockout cell lysate ab280114). To generate this image wild-type and PRKAA1 knockout RAW 264.7 cell lysates were analysed. First samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°. Blots were washed four times in TBS-T incubated with secondary antibodies for 1 h at room temperature washed again four times then imaged.Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

All lanes:

Western blot - Anti-AMPK alpha 1 antibody [2B7] (<a href='/en-us/products/primary-antibodies/ampk-alpha-1-antibody-2b7-ab110036'>ab110036</a>) at 1/500 dilution

Lane 1:

Wild-type RAW 264.7 cell lysate at 20 µg

Lane 2:

PRKAA1 knockout RAW 264.7 cell lysate at 20 µg

Lane 2:

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell line (ab280055)

Lane 3:

Mouse Liver cell lysate at 20 µg

Lane 4:

Neuro2A cell lysate at 20 µg

Predicted band size: 64 kDa

Observed band size: 64 kDa

false

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell line (AB280055)
  • WB

Lab

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell line (AB280055)

False colour image of Western blot : Anti-AMPK alpha 1 antibody [Y365] staining at 1/1000 dilution shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution shown in red. In Western blot ab32047 was shown to bind specifically to AMPK alpha 1. A band was observed at 64 kDa in wild-type RAW 264.7 cell lysates with no signal observed at this size in PRKAA1 knockout cell line ab280055 (knockout cell lysate ab280114). To generate this image wild-type and PRKAA1 knockout RAW 264.7 cell lysates were analysed. First samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °. Blots were washed four times in TBS-T incubated with secondary antibodies for 1 h at room temperature washed again four times then imaged.Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-AMPK alpha 1 antibody [Y365] (<a href='/en-us/products/primary-antibodies/ampk-alpha-1-antibody-y365-ab32047'>ab32047</a>) at 1/1000 dilution

Lane 1:

Wild-type RAW 264.7 cell lysate at 20 µg

Lane 2:

PRKAA1 knockout RAW 264.7 cell lysate at 20 µg

Lane 2:

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell line (ab280055)

Lane 3:

Mouse Liver cell lysate at 20 µg

Lane 4:

Neuro2A cell lysate at 20 µg

Predicted band size: 64 kDa

Observed band size: 64 kDa

false

Sanger Sequencing - Mouse PRKAA1 knockout RAW 264.7 cell line (AB280055)
  • Sanger seq

Supplier Data

Sanger Sequencing - Mouse PRKAA1 knockout RAW 264.7 cell line (AB280055)

Mouse Prkaa1 KO in Raw264.7 Cells with 2 bp deletion in Exon 4

Key facts

Cell type

RAW 264.7

Species or organism

Mouse

Tissue

Lymphatic

Form

Liquid

form

Knockout validation

Sanger Sequencing,Western blot

Disease

Carcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab280055-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab275474 Mouse wild-type RAW 264.7 cell line", "number":"AB280055-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab280055 Mouse PRKAA1 knockout RAW 264.7 cell line", "number":"AB280055-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab280055-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab280055 Mouse PRKAA1 knockout RAW 264.7 cell line", "number":"AB280055-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
PRKAA1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water for bath approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method all remaining cells into an ultra-low attachment T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent.
5. Once confluent passage into an appropriate flask at a density of 2x105 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • Grow in ultra-low attachment flasks.
  • Do not wash or use dissociation reagent. Cells are semi-adherent. Tap flask sharply to remove adhered cells.
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x105 cells/mL is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PRKAA1 also known as the alpha 1 catalytic subunit of AMP-activated protein kinase (AMPK) plays an important role in cellular energy homeostasis. It has a molecular mass of approximately 63 kDa. The protein is widely expressed in various tissues including the liver skeletal muscle and brain. As a serine/threonine kinase PRKAA1 reacts to changes in cellular energy status by activating pathways that restore energy balance.
Biological function summary

PRKAA1 acts as an energy sensor and regulator in cells. As part of the AMPK heterotrimeric complex it regulates energy metabolism by phosphorylating various substrates involved in lipid glucose and protein metabolism. PRKAA1 activation results in increased glucose uptake fatty acid oxidation and mitochondrial biogenesis while inhibiting the synthesis of fatty acids cholesterol and triglycerides. This protein plays a significant role in maintaining cellular energy homeostasis and adapting to metabolic stress.

Pathways

PRKAA1 links to both the mTOR signaling pathway and the insulin signaling pathway. In the mTOR pathway it interacts with proteins such as TSC2 and Raptor leading to the inhibition of mTORC1 activity. In the insulin signaling pathway PRKAA1 affects the phosphorylation state of proteins involved in glucose homeostasis. PRKAA1's regulation of these pathways highlights its importance in metabolic processes and energy balance.

PRKAA1 shows association with metabolic disorders like type 2 diabetes and obesity. In type 2 diabetes dysregulation of PRKAA1-related pathways impacts insulin sensitivity and glucose uptake contributing to disease progression. Furthermore PRKAA1 relates to cardiac diseases often involving proteins such as PGC-1α which is important for mitochondrial biogenesis and energy metabolism in heart tissues. Understanding PRKAA1's role offers insights into potential therapeutic targets for these metabolic diseases.

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com